CRISPR Therapeutics AG Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARK INVESTMENT MANAGEMENT LLC | 08/14/2026 | 9.46 M | $516.00 M | -16.38% | 9.85% |
| BLACKROCK, INC. | 08/07/2026 | 8.35 M | $455.35 M | 8.71% | 8.69% |
| ORBIS ALLAN GRAY LTD | 08/14/2026 | 5.45 M | $297.20 M | -10.76% | 5.67% |
| CAPITAL WORLD INVESTORS | 08/12/2026 | 4.75 M | $259.04 M | 0.52% | 4.94% |
| STATE STREET CORP | 08/07/2026 | 4.32 M | $235.70 M | 8.52% | 4.50% |
| GSK PLC | 08/13/2026 | 3.22 M | $175.65 M | 0.00% | 3.35% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 2.51 M | $136.92 M | 5.58% | 2.61% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 2.05 M | $111.97 M | -30.47% | 2.14% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/12/2026 | 2.04 M | $111.19 M | 0.00% | 2.12% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2026 | 1.99 M | $108.46 M | 34.09% | 2.07% |
| FMR LLC | 08/13/2026 | 1.91 M | $104.09 M | -2.36% | 1.99% |
| SUMITOMO MITSUI TRUST GROUP, INC. | 07/30/2026 | 1.72 M | $93.85 M | -7.18% | 1.79% |
| NIKKO ASSET MANAGEMENT AMERICAS, INC. | 08/13/2026 | 1.72 M | $93.76 M | -7.22% | 1.79% |
| ECOR1 CAPITAL, LLC | 08/14/2026 | 1.39 M | $75.77 M | 0.00% | 1.45% |
| UBS GROUP AG | 08/13/2026 | 1.32 M | $71.86 M | -25.25% | 1.37% |
| CAPITAL INTERNATIONAL INVESTORS | 08/12/2026 | 1.27 M | $69.18 M | 6.88% | 1.32% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.18 M | $64.46 M | 3.44% | 1.23% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 1.16 M | $63.00 M | 17.50% | 1.20% |
| NEA MANAGEMENT COMPANY, LLC | 08/14/2026 | 1.06 M | $57.73 M | 0.00% | 1.10% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 1.06 M | $57.69 M | 1.78% | 1.10% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 1.06 M | $57.69 M | 100.00% | 1.10% |
| D. E. SHAW & CO., INC. | 08/14/2026 | 893.81 K | $48.75 M | 100.00% | 0.93% |
| MORGAN STANLEY | 08/13/2026 | 879.95 K | $47.99 M | 31.70% | 0.92% |
| NORTHERN TRUST CORP | 08/13/2026 | 863.09 K | $47.07 M | 7.59% | 0.90% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 648.71 K | $35.38 M | 18.63% | 0.68% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 570.04 K | $31.09 M | 5.04% | 0.59% |
| CITADEL ADVISORS LLC | 08/14/2026 | 465.80 K | $25.40 M | -9.79% | 0.48% |
| JPMORGAN CHASE & CO | 08/12/2026 | 431.67 K | $24.57 M | -5.67% | 0.45% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 427.18 K | $23.30 M | -28.01% | 0.44% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 382.03 K | $20.84 M | 1.29% | 0.40% |
| IQ EQ FUND MANAGEMENT (IRELAND) LTD | 07/31/2026 | 381.99 K | $20.83 M | -4.71% | 0.40% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 338.40 K | $18.46 M | -30.56% | 0.35% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 326.76 K | $17.82 M | 4.94% | 0.34% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 325.70 K | $17.76 M | -42.50% | 0.34% |
| LOGOS GLOBAL MANAGEMENT LP | 08/14/2026 | 300.00 K | $16.36 M | 100.00% | 0.31% |
| CITADEL ADVISORS LLC | 08/14/2026 | 290.10 K | $15.82 M | -49.31% | 0.30% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 286.79 K | $15.64 M | 86.74% | 0.30% |
| JUMP FINANCIAL, LLC | 08/13/2026 | 277.95 K | $15.16 M | 158.71% | 0.29% |
| DIMENSIONAL FUND ADVISORS LP | 08/11/2026 | 275.38 K | $15.03 M | -44.28% | 0.29% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 272.37 K | $14.86 M | -34.24% | 0.28% |
| NORGES BANK | 08/12/2026 | 270.76 K | $14.77 M | 100.00% | 0.28% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 263.17 K | $14.35 M | -6.25% | 0.27% |
| CITADEL ADVISORS LLC | 08/14/2026 | 256.20 K | $13.97 M | -1.04% | 0.27% |
| AMERIPRISE FINANCIAL INC | 08/14/2026 | 250.61 K | $13.67 M | -12.63% | 0.26% |
| VESTMARK ADVISORY SOLUTIONS, INC. | 08/14/2026 | 242.27 K | $13.21 M | -5.65% | 0.25% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 231.99 K | $12.65 M | 5.32% | 0.24% |
| JANE STREET GROUP, LLC | 08/14/2026 | 230.40 K | $12.57 M | -60.00% | 0.24% |
| PEAK6 LLC | 08/13/2026 | 213.30 K | $11.63 M | -27.91% | 0.22% |
| NUVEEN, LLC | 08/11/2026 | 203.09 K | $11.08 M | 6.46% | 0.21% |
| ROYAL BANK OF CANADA | 08/14/2026 | 173.05 K | $9.44 M | 5.70% | 0.18% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
CRISPR Therapeutics AG institutional Ownership - FAQ's
During the previous two years, 710 institutional investors and hedge funds held shares of CRISPR Therapeutics AG. The most heavily invested institutionals were:
ARK Investment Management LLC: 9.46 M
BlackRock, Inc.: 8.35 M
Orbis Allan Gray Ltd: 5.45 M
Capital World Investors: 4.75 M
STATE STREET CORP: 4.32 M
GSK PLC: 3.22 M
80.43% of CRISPR Therapeutics AG stock is owned by institutional investors.
Institutional investors have bought a total of 86.91 M shares in the last 24 months. This purchase volume represents approximately $5.11 B in transactions.